Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep1071 | Thyroid | ECE2022

Moyamoya disease and Graves’ disease in a Tunisian girl

Bel Hadj Sliman Chayma , Chaker Fatma , Grassa Anis , Khessairi Nadia , Oueslati Ibtissem , Chihaoui Melika

Introduction: There is an association between Moyamoya syndrome and GravesÂ’ disease, described primarily in Asian populations. We report a case of Moyamoya vasculopthy with stroke and hypertension associated with gravesÂ’ disease in a 15-year-old Tunisian girl.Observation: A 15-year-old girl diagnosed with Moyamoya vasculopathy was referred to the endocrinology department for hyperthyroidism. The patient had a history of recurrent stroke and hyp...

ea0081ep1162 | Thyroid | ECE2022

Hypothyroidism : the interest of thyroid hormone test

Mouelhi Yasmine , Khessairi Nadia , Terzi Ameni , Grira Wafa , Yazidi Meriem , Chihaoui Melika

Introduction: Hypothyroidism is a common endocrine disease with reduced systemic metabolism and its treatment consists on hormonal supplementation. However, despite concurrent replacement therapy with high doses of L-thyroxin, some patients might be seen with clinical and biochemical evidence of hypothyroidism. We report a case of persistent hypothyroidism on high dose of levothyroxin.Case presentation: It was a 41-year-old female, with a history of recu...

ea0090p146 | Pituitary and Neuroendocrinology | ECE2023

Dopamine agonist-resistance in patients with macroprolactinoma: prevalence and predictive factors

Terzi Ameni , Oueslati Ibtissem , Hadj Sliman Chayma Bel , Abid Arige , Yazidi Meriem , Chihaoui Melika

Introduction: Dopamine agonists, mainly cabergoline and bromocriptine, represent the first-line treatment option in the management of prolactinomas. They allow prolactin normalization and tumor shrinkage. However, a subset of individuals with macroprolactinoma could exhibit a varying degree of resistance to dopamine agonists. The aim of this study was to determine the prevalence of dopamine agonist-resistance in patients with macroprolactinoma and to assess its predictive fact...

ea0090p155 | Pituitary and Neuroendocrinology | ECE2023

Development of a new score to predict dopamine agonist resistance in patients with macroprolactinoma

Terzi Ameni , Oueslati Ibtissem , Hadj Sliman Chayma Bel , Ayari Sabrina , Yazidi Meriem , Chihaoui Melika

Introduction: Surgical treatment is indicated in patients with dopamine agonist-resistant macroprolactinoma. However, the resection of the tumor is usually partial because of fibrotic changes under long-term dopamine agonist therapy. Thus, early identification and management of patients at high risk of dopamine agonist resistance is crucial to a complete resection outcome and a better remission. The aim of this study was to develop a score predicting dopamine agonist resistanc...

ea0090ep40 | Adrenal and Cardiovascular Endocrinology | ECE2023

Effects of high-dose atorvastatin treatment on adrenal steroidogenesis in type 2 diabetes patients

Terzi Ameni , Khessairi Nadia , Oueslati Ibtissem , Yazidi Meriem , Bassem Hammami , Chaker Fatma , Moncef Feki , Chihaoui Melika

Introduction: Statins are widely used to prevent cardiovascular diseases. Nonetheless, reducing cholesterol, the main substrate for steroidogenesis, may impair cortisol production. The aim of our study was to assess the effect of high dose statin therapy on cortisol and dehydroepiandrosterone-sulphate (DHEA-S) levels in type 2 diabetes male patients.Methods: This was a single-center, prospective study, during the period march 2021 - July 2022, including ...

ea0090ep76 | Adrenal and Cardiovascular Endocrinology | ECE2023

Impact of long-term atorvastatin use on renal function in type 2 diabetes patients

Terzi Ameni , Khessairi Nadia , Yazidi Meriem , Oueslati Ibtissem , Bassem Hammami , Chaker Fatma , Moncef Feki , Chihaoui Melika

Introduction: Statins are widely used in primary and secondary cardiovascular prevention. They have been described to improve renal function. We aimed in this study to evaluate the effect of high dose atorvastatin therapy on renal outcome in type 2 diabetes patients.Methods: This was a single-center, prospective study, including 60 men with type 2 diabetes mellitus, aged between 40 and 65 years, statin-free, in whom the indication of a high dose statin t...

ea0090ep146 | Calcium and Bone | ECE2023

The calcium-to-phosphorus ratio in the diagnosis of parathyroid disorders

Faten Cherchir , Oueslati Ibtissem , Abid Arige , Aloui Emna , Yazidi Meriem , Chihaoui Melika

Introduction: The diagnosis of primary hyperparathyroidism and hypoparathyroidism is still challenging because of the increasing frequency of non-classical presentations. The calcium-to-phosphorus ratio (Ca/P) (CPR) is an inexpensive biochemical marker that could be useful to diagnose parathyroid disorders.Aim: The aim of this study was to assess the performances of CPR in the diagnosis of primary hyperparathyroidism and hypoparathyroidism.<p class="...

ea0090ep169 | Calcium and Bone | ECE2023

Deep vein thrombosis revealing primary hyperparathyroidism

Abid Arige , Oueslati Ibtissem , Bouzidi Mayssa , Yazidi Meriem , Lamloum Mounir , Chihaoui Melika

Introduction: Primary hyperparathyroidism is a common endocrine disease. Its association with inflammatory and thrombotic events was rarely reported in the literature. The pathophysiological mechanisms of this association remain uncertain. Herein, we report a case of hypercalcemia secondary to primary hyperparathyroidism revealed by a deep vein thrombosis.Observation: A 65-year-old patient was referred to our department for primary hyperparathyroidism. T...

ea0090ep257 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Hyperhomocysteinemia in type 2 diabetes, a risk factor for the complications of diabetes?

Kamoun Elyes , Yazidi Meriem , Taieb Sameh Hadj , Khessairi Nadia , Oueslati Ibtissem , Chihaoui Melika

Introduction: Patients with type 2 diabetes mellitus are considered at least at high cardio-vascular risk. Cardiovascular risk factors must be regularly screened. Hyperhomocysteinemia is considered as an independent risk factor for atherosclerotic disease and coronary disease in some studies. The aim of our study was to confirm the association between hyperhomocysteinemia and atherosclerotic disease in patients with type 2 diabetes.Methods: We performed ...

ea0090ep661 | Environmental Endocrinology | ECE2023

Endocrine complications in patients of beta thalassemia major

Khessairi Nadia , Grassa Anis , Meziou Nour , Mrad Mehdi , Mahjoub Sonia , Bahlous Afef , Chihaoui Melika

Introduction: Endocrine complications are common in beta thalassemia major (BTM) patients receiving blood transfusions. Chelation therapy has a role in preventing such complications. However, patients may have difficulties adhering to chelation therapy. We aimed in this study to determine the endocrine complications in BTM patients.Methods: This was a descriptive study with cross-sectional data collection over a 6 month period from February 2022 to July ...